CapsoVision, Inc (CV) stock
Close on Nov 11, 2026Market cap $313.79MP/E –Yield –
CapsoVision, Inc grew revenue 11.0% to $13.89M over the twelve months to Jun 30, 2026. Free cash flow was -$27.89M. At the latest close the market valued the company at $313.79M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $313.79M
- P/E ratio
- –
- Price to sales
- 22.59
- Price to book
- 23.83
- Dividend yield
- –
- Free cash flow yield
- -8.89%
Fundamentals
- Revenue
- $13.89M
- Net income
- -$29.83M
- EPS, diluted
- -$1.03
- Free cash flow
- -$27.89M
- Book value per share
- $0.26
- Diluted shares
- 50M
Trading
- Next earnings
- Nov 12, 2026 (estimated, during market hours)
- Previous close
- $6.37
- Open
- $6.42
- Day's range
- $6.27 – $6.58
- Volume
- 58,566
- Average volume (20 days)
- 131,808
- Index membership
- Russell 2000 (since Dec 2025)
- 52-week range
- $4.50 – $15.37
- RSI (14 days)
- 42.3
- Volatility (1 year)
- 98.4%
- Relative volume
- 0.38×
On 1 of our idea list: Insiders buying the dip
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CV | S&P 500 | Difference | CV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.9% | -2.4% | −2.4 pts | ||
| 3 months | -5.0% | -1.2% | −3.8 pts | ||
| Year to date | -41.3% | +12.3% | −53.6 pts | ||
| 1 year | +15.2% | +12.4% | +2.7 pts | ||
| 3 years | -82.2% | +78.8% | −161.0 pts | -43.8% | +21.4% |
| 5 years | -82.2% | +75.2% | −157.4 pts | -29.2% | +11.9% |
| 10 years | -82.2% | +311.1% | −393.3 pts | -15.9% | +15.2% |
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases CapsoVision filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Update
- Results
- Results
- Results
About CapsoVision
Electromedical & Electrotherapeutic Apparatus
The company is a medical technology firm that develops diagnostic and screening products for identifying abnormalities in the gastrointestinal tract. Its principal commercial offering is the CapsoCam capsule endoscopy system, which includes the CapsoCam Plus single-use capsule that captures panoramic images with onboard storage, along with viewing software platforms known as CapsoCloud and CapsoView. The company is also developing the CapsoCam Colon capsule and auxiliary products such as a delivery device and a patency capsule. Its primary customers are gastroenterologists practicing in clinics and hospital settings.
Company profile, executives and historyCapsoVision stock: common questions
What is CapsoVision's stock price?
CV closed at $6.27 on Nov 11, 2026, down 1.57% on the day. Over the past 52 weeks it traded between $4.50 and $15.37.
What is CapsoVision's market cap?
CapsoVision was worth $313.79M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CV's P/E ratio?
CapsoVision lost money over fiscal 2025 (diluted EPS -$1.03), so it has no meaningful P/E ratio.
How much revenue does CapsoVision make?
CapsoVision reported revenue of $13.89M for the twelve months to Jun 30, 2026, up 11.0% from a year earlier.
Does CapsoVision pay a dividend?
No. CapsoVision has not paid a cash dividend over the last twelve months.
When does CapsoVision report earnings next?
CapsoVision is expected to report Q3 FY2026 results on Nov 12, 2026, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has CV stock performed over the past year?
Including dividends, CV returned +15.2% over the past year, against +12.4% for the S&P 500.
How many CV shares are sold short?
2M shares were sold short at the latest FINRA report, 5.21% of the float, or 14.3 days of average trading volume.
Who are CapsoVision's competitors?
Companies most similar to CapsoVision by business, industry and size include ESMC, HYPR, QTI, NRXS, IRIX.
See a number that looks wrong?